Authorship change form from Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers
Authors:
- Oliver KleinOKOliver Klein
- Damien KeeDKDamien Kee
- Ben MarkmanBMBen Markman
- Michael MichaelMMMichael Michael
- Craig UnderhillCUCraig Underhill
- Matteo S. CarlinoMCMatteo S. Carlino
- Louise JackettLJLouise Jackett
- Caroline LumCLCaroline Lum
- Clare ScottCSClare Scott
- Adnan NagrialANAdnan Nagrial
- Andreas BehrenAndreas Behren
- Jane Y. SoJSJane Y. So
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)